Using peripheral blood mRNA signature to distinguish between breast cancer and benign breast disease in non-conclusive mammography patients

Cancer Biology and Therapy

Volumn 10, Issue 12, 2010, Pages 1235-1239

  Yang, Benlong ^a,b   Xu, Qinghua ^a,c   Wu, Fei ^c   Liu, Fang ^c   Ye, Xun ^c   Liu, Guangyu ^a,b   Zhimin Shao, ^a,b   Meng, Xia ^d   Mougin, Bruno ^d   Wu, Jiong ^a,b  

^a Department of Breast Surgery ^*  (China)

^b FUDAN UNIVERSITY   (China)

^c FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^d BIOMÉRIEUX   (France)

Author keywords

Benign breast disease; BI RADS; Biomarker; Breast cancer; Mammography; Microarray; Signature

Indexed keywords

BIOLOGICAL MARKER; DNA; MESSENGER RNA;

ADULT; AGED; ARTICLE; BLOOD; BLOOD SAMPLING; BREAST CANCER; BREAST DISEASE; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMAGING; MAJOR CLINICAL STUDY; MALE; MAMMOGRAPHY; PATHOLOGY; RNA EXTRACTION;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; BREAST DISEASES; BREAST NEOPLASMS; FEMALE; HUMANS; MAMMOGRAPHY; MICROARRAY ANALYSIS; MIDDLE AGED; NUCLEIC ACID AMPLIFICATION TECHNIQUES; RNA, MESSENGER;

EID: 78650400863     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.10.12.13437     Document Type: Article

References (25)

1. Thomas DB, Gao DL, Ray RM, Wang WW, Allison CJ, Chen FL, et al. Randomized trial of breast selfexamination in Shanghai: final results. J Natl Cancer Inst 2002; 94:1445-57.
2. Tabár L, Fagerberg CJ, Gad A, Baldetorp L, Holmberg LH, Gröntoft O, et al. Reduction in mortality from breast cancer after mass screening with mammography. Lancet 1985; 1:829-34.
3. Aarøe J, Lindahl T, Dumeaux V, Saebø S, Tobin D, Hagen N, et al. Gene expression profiling of peripheral blood cells for early detection of breast cancer. Breast Cancer Research 2010; 12:7.
4. American College of Radiology. The ACR breast imaging reporting and data system (BI-RADS) [web source]. November 11, 2003. Available from: http://www.acr.org/departments/stand-accred/birads/contents.html. Accessed February 27 2004.
5. Liberman L, Menell JH. Breast imaging reporting and data system (BI-RADS). Radiol Clin North Am 2002; 40:409-30.
6. Eberl M. MPH, Fox C, Edge S, Carter C, Mahoney M. BI-RADS Classification for Management of Abnormal Mammograms. J Am Board Fam Med 2006; 19:161-4.
7. Eskelinen M, Kataja V, Hämäläinen E, Kosma VM, Penttilä I, Alhava E. Serum tumour markers CEA AFP, CA 15-3, TPS and Neu in diagnosis of breast cancer. Anticancer Res 1997; 17:1231-4.
8. Whitney AR, Diehn M, Popper SJ, Alizadeh AA, Boldrick JC, Relman DA, et al. Individuality and variation in gene expression patterns in human blood. Proc Natl Acad Sci USA 2003; 100:1896-901.
9. Sharma P, Sahni NS, Tibshirani R, Skaane P, Urdal P, Berghagen H, et al. Early detection of breast cancer based on gene-expression patterns in peripheral blood cells. Breast Cancer Res 2005; 7:634-44.
10. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, et al. Exploration, normalization and summaries of high density oligonucleotide array probe level data. Biostatistics 2003; 4:249-64.
11. Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 2007; 8:118-27.
12. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001; 98:5116-21.
13. Team RDC. R: A Language and Environment for Statistical Computing. Vienna, Austria 2009.
14. Wilson CL, Miller CJ. Simpleaffy: a BioConductor package for Affymetrix Quality Control and data analysis. Bioinformatics 2005; 21:3683-5.
15. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004; 5:80.
16. Sardanelli F, Podo F, D'Agnolo G, Verdecchia A, Santaquilani M, Musumeci R, et al. Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results. Radiology 2007; 24:698-715.
17. Lehman CD. Role of MRI in screening women at high risk for breast cancer. J Magn Reson Imaging 2006; 24:964-70.
18. Leconte I, Feger C, Galant C, Berlière M, Berg BV, D'Hoore W, et al. Mammography and subsequent whole-breast sonography of nonpalpable breast cancers: the importance of radiologic breast density. AJR Am J Roentgenol 2003; 180:1675-9.
19. Kolb TM, Lichy J, Newhouse JH. Comparison of the performance of screening mammography, physical examination and breast ultrasound and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology 2002; 225:165-75.
20. Beck J, Urnovitz HB, Mitchell WM, Schutz E. Next generation sequencing of serum circulating nucleic acids from patients with invasive ductal breast cancer reveals differences to healthy and nonmalignant controls. Mol Cancer Res 2010; 8:335-42.
21. André F, Michiels S, Dessen P, Scott V, Suciu V, Uzan C, et al. Exonic expression profiling of breast cancer and benign lesions: a retrospective analysis. Lancet Oncol 2009; 10:381-90.
22. Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD. Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 2002; 3:991-8.
23. Viprey VF, Lastowska MA, Corrias MV, Swerts K, Jackson MS, Burchill SA. Minimal disease monitoring by QRT-PCR: guidelines for identification and systematic validation of molecular markers prior to evaluation in prospective clinical trials. J Pathol 2008; 216:245-52.
24. Geiss GK, Bumgarner RE, Birditt B, Dahl T, Dowidar N, Dunaway DL, et al. Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat Biotechnol 2008; 26:317-25.
25. Zhang L, Zhang M, Yang S, Cao Y, Bingrong Zhang S, Yin L, et al. A new biodosimetric method: branched DNA-based quantitative detection of B1 DNA in mouse plasma. Br J Radiol 2010; 83:694-701.